You are here

R&D

Heptares nabs $5M from Teva for new migraine molecule

Fierce Biotech

Thu, 05/18/17 - 10:09 am

Heptares Therapeutics

drug development

Teva Pharmaceutical

She’s got a radical approach for the age of superbugs: Don’t fight infections. Learn to live with them

Stat

Thu, 05/18/17 - 09:42 am

drug development

Cloud-based Biotech: Managing Data for All Stages of Drug Development

Xtalks

Tue, 05/16/17 - 10:36 pm

drug development

Pharma's Not So Stingy With R&D After All

Forbes

Mon, 05/15/17 - 09:42 am

pharma industry

PhRMA ousts 22 drugmakers from ranks in membership change

BioPharma Dive

Thu, 05/11/17 - 11:18 am

Novartis pushes further into pain with Durect deal

BioPharma Dive

Tue, 05/9/17 - 10:45 pm

Takeda pens GammaDelta Therapeutics $100M pact, with M&A option

Fierce Biotech

Tue, 05/9/17 - 10:21 am

GammaDelta Therapeutics

gamma delta T cells

3 Things to Watch With Gilead Sciences, Inc. Q1 Results

Motley Fool

Sun, 04/30/17 - 12:52 pm

Gilead Sciences

Four Decades Of Hacking Biotech And Yet Biology Still Consumes Everything

Forbes

Wed, 04/26/17 - 11:47 am

drug development

AstraZeneca moving costs rise as new HQ nears completion

Yahoo/Reuters

Tue, 04/25/17 - 11:06 am

Biopharma opening up to new ways of partnering on R&D

BioPharma Dive

Thu, 04/20/17 - 09:04 pm

Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO

Endpoints

Tue, 04/18/17 - 08:58 pm

G1 Therapeutics

A final flop signals the bitter end to Circassia’s big plans for allergy R&D

Endpoints

Tue, 04/18/17 - 09:34 am

Democrats Propose A $2B Prize Fund For New Antibiotics

Forbes

Wed, 04/12/17 - 11:51 am

drug develoment

Improving Access to Affordable Prescription Drugs Act

GSK vaccine R&D exec: Get to work now on the next emerging disease outbreak

Fierce Pharma

Wed, 04/12/17 - 10:31 am

emerging diseases

Takeda continues global R&D reboot with a new joint venture with PRA

Endpoints

Sat, 04/8/17 - 12:46 pm

Mallinckrodt exits PhRMA before new rules take hold

BioPharma Dive

Thu, 04/6/17 - 11:56 pm

Actelion shareholders OK R&D spinout

Drug Delivery Business News

Wed, 04/5/17 - 12:04 pm

Amgen will move 100 workers to San Francisco, Cambridge as part of restructuring

Bizjournals.com

Tue, 04/4/17 - 12:15 am

Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents

Yahoo

Thu, 03/30/17 - 09:35 am

Bristol-Myers Squibb

Foundation Medicine

Pages